Providence First Trust Co

Bank

Position in LLY — ELI LILLY & Co

CIK 1713735 SCOTTSDALE, AZ

Position in LLY

as of Jun 30, 2026 · filed Jul 27, 2026 Compact

Position Value

$1,268,997

+$145,039 QoQ

Shares Held

1,058

-13.4% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

1.15%

of 13F equity value

Holder Rank

#2,912

of 4,604 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Providence First Trust Co holds $5,635,150 across 8 Drug Manufacturers - General names. LLY ranks #1 (22.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co This page	1,058	$1,268,997
2	JNJ	Johnson & Johnson	3,806	$966,609
3	BIIB	Biogen Inc.	4,175	$902,050
4	MRK	Merck & Co., Inc.	5,849	$751,596
5	AZN	Astrazeneca PLC	3,092	$586,305
6	GILD	Gilead Sciences, Inc.	3,775	$476,933
7	AMGN	Amgen Inc	979	$354,515
8	BMY	Bristol Myers Squibb Co	5,695	$328,145

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,268,997	1,058	-13.4%	Shares	Sole	2026-07-27
2026-03-31	$1,123,958	1,222	-7.1%	Shares	Sole	2026-05-05
2025-12-31	$1,413,204	1,315	-38.9%	Shares	Sole	2026-02-03
2025-09-30	$1,641,213	2,151	-2.8%	Shares	Sole	2025-10-29
2025-06-30	$1,725,879	2,214	+0.1%	Shares	Sole	2025-08-01
2025-03-31	$1,826,087	2,211	0.0%	Shares	Sole	2025-05-12
2024-12-31	$1,706,892	2,211	-6.2%	Shares	Sole	2025-02-05
2024-09-30	$2,088,160	2,357	+159.3%	Shares	Sole	2024-11-12
2024-06-30	$822,990	909	-46.8%	Shares	Sole	2024-08-01
2024-03-31	$1,329,533	1,709	+263.6%	Shares	Sole	2024-05-13
2023-12-31	$273,972	470	—	Shares	Sole	2024-02-07
No filing history on record for this holder in this stock.